Cleared Traditional

K051825 - COGNITRACE

K051825 is an FDA 510(k) clearance for COGNITRACE, manufactured by Eemagine Medical Imaging Solutions GmbH. The device is a Class 2 Neurology device with product code GWQ cleared through the Traditional 510(k) pathway after a 69-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2005
Decision
69d
Days
Class 2
Risk

K051825 is an FDA 510(k) clearance for the COGNITRACE. Classified as Full-montage Standard Electroencephalograph (product code GWQ), Class II - Special Controls.

Submitted by Eemagine Medical Imaging Solutions GmbH (Deer Field, US). The FDA issued a Cleared decision on September 12, 2005 after a review of 69 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.1400 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Eemagine Medical Imaging Solutions GmbH devices

FDA 510(k) Submission Details - K051825

510(k) Number K051825 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 05, 2005
Decision Date September 12, 2005
Days to Decision 69 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
79d faster than avg
Panel avg: 148d · This submission: 69d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GWQ Device Classification - Class 2, Special Controls

Product Code GWQ Full-montage Standard Electroencephalograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.1400
Definition Acquire, Display, Store, And Archive Electroencephalographic Signals From The Brain Using A Full Montage Array (i.e., 16 Or More Electrodes) And User-specified Locations
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GWQ Full-montage Standard Electroencephalograph

All 97
Devices cleared under the same product code (GWQ) and FDA review panel - the closest regulatory comparables to K051825.
NIHON KOHDEN EEG-1200A WITH JE-120A MULTI CHANNEL ELECTRODE JUNCTION BOX
K113117 · Nihon Kohden America, Inc. · Mar 2012
ENTROPY EASYFIT SENSOR
K103129 · Ge Healthcare · Jul 2011
XLTEK EMU40 EEG HEADBOX, MODEL PK1072
K053386 · Excel Tech. , Ltd. · Apr 2006
XLTEK TREX MODEL#10309
K042150 · Excel Tech. , Ltd. · Aug 2004
EMU128S, MODEL EX-NW-128S
K040360 · Excel Tech. , Ltd. · Mar 2004
96 CHANNEL EEG HEADBOX MODEL EMU96
K021599 · Excel Tech. , Ltd. · Aug 2002